Related Experiment Video
Updated: Apr 26, 2026

05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
453
[General practitioner relevant recommendations in German cancer guidelines: a systematic review]
Andrea Siebenhofer1, Karl Horvath2, Thomas Semlitsch3
1Institut für Allgemeinmedizin, Goethe-Universität Frankfurt am Main, Deutschland.
Summary
German cancer guidelines rarely involve general practitioners (GPs) in their development. Most recommendations are not directly applicable to family practice, limiting their utility for primary cancer care.
Area of Science:
- Oncology
- General Practice
- Health Services Research
Background:
- The "Cancer Care in the Family Practice" project investigated the role of general practitioners (GPs) in German cancer guidelines.
- This study aimed to assess GP inclusion in the formulation of these guidelines.
Purpose of the Study:
- To evaluate the extent to which general practitioners (GPs) are considered in the development of German cancer guidelines.
- To determine the applicability of guideline recommendations for primary care.
Main Methods:
- A systematic search of national guideline portals identified 29 relevant cancer care guidelines.
- Guidelines were analyzed for references to general practice programs, GP involvement in development, and GP target group status.
- Recommendations relevant to GPs were categorized and quantitatively assessed.
Main Results:
- Only 8 of 29 guidelines involved GPs in their development; 4 directly addressed GPs as a target group.
- 21 guidelines referenced general practice cancer care programs, but none mentioned family practice-specific programs.
- Most recommendations fell under 'communication' but often included measures not directly implementable by GPs.
Conclusions:
- German cancer guidelines show limited inclusion of general practitioners (GPs) in their development.
- A significant gap exists in guideline recommendations directly applicable to family practice settings.
- Guideline relevance to GPs is influenced by development stage and scope (tumor-specific vs. general).
Related Concept Videos
Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Cancer Survival Analysis
857
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K